# Chengdu Shengnuo Biopharm Co Ltd, Chengdu, China – FDA Inspections

Source: https://www.keypedia.com/companies/chengdu-shengnuo-biopharm-co-ltd/7e22dc83-be1b-41e1-af8c-856dd7a35375

> Inspection records and compliance data for Chengdu Shengnuo Biopharm Co Ltd in Chengdu. 5 FDA inspections on record, 2 Form 483s, last inspected August 27, 2026.

---

## Details

- Name: Chengdu Shengnuo Biopharm Co Ltd
- FEI Number: 3006257504
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING
- Address Line 1: No. 258 Section 1, Xueshan Avenue, Qingxia Street, Dayixian
- City: Chengdu
- Country Name: China
- Address: No. 258 Section 1, Xueshan Avenue, Qingxia Street, Dayixian, Chengdu, China
- Country: China

## Related Documents

- [483 - Chengdu Shengnuo Biopharm Co Ltd - 2026-08-27](https://www.keypedia.com/records/483/chengdu-shengnuo-biopharm-co-ltd/a7cd067e-1b0c-424b-a2e8-a52a3c2ec61d) — source: FDA, date: August 27, 2026
- [FDA Inspection 1334998 - Chengdu Shengnuo Biopharm Co Ltd - 2026-08-27](https://www.keypedia.com/records/fda_inspections/chengdu-shengnuo-biopharm-co-ltd/8579538b-d6b3-4b81-b520-51c8447f010d) — source: FDA, date: August 27, 2026
- [483 - Chengdu Shengnuo Biopharm Co Ltd - 2023-09-08](https://www.keypedia.com/records/483/chengdu-shengnuo-biopharm-co-ltd/3a5fc8ce-c04d-40a6-8c94-70d6a944c6dc) — source: FDA, date: September 8, 2023
- [FDA Inspection 1219460 - Chengdu Shengnuo Biopharm Co Ltd - 2023-09-08](https://www.keypedia.com/records/fda_inspections/chengdu-shengnuo-biopharm-co-ltd/9c07302f-5743-4fd1-8da4-72f5e26f2e72) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 8, 2023
- FDA Inspection 978495 - Chengdu Shengnuo Biopharm Co Ltd - 2016-06-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 10, 2016
- FDA Inspection 924616 - Chengdu Shengnuo Biopharm Co Ltd - 2015-04-09 — classification: No Action Indicated (NAI), source: FDA, date: April 9, 2015
- FDA Inspection 784098 - Chengdu Shengnuo Biopharm Co Ltd - 2012-05-24 — classification: No Action Indicated (NAI), source: FDA, date: May 24, 2012

## Related Companies

- [Henan Lihua Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/henan-lihua-pharmaceutical-co-ltd/0fcfa9cb-e461-4a79-b60a-20bd1198621a)
- [Shenzhen Oriental Pharmaceutical Co Ltd](https://www.keypedia.com/companies/shenzhen-oriental-pharmaceutical-co-ltd/71227651-964f-4f33-a24b-5c0b0f6c92a0)
- [Azico Biophore India Private Limited](https://www.keypedia.com/companies/azico-biophore-india-private-limited/373fe2a1-5910-425f-8478-71be63a40f32)
- [SRI Krishna Pharmaceuticals Ltd - Unit I](https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-ltd-unit-i/a8609781-dc13-4ad6-9bb3-047ead2bf151)
- [Kreative Organics Private Limited](https://www.keypedia.com/companies/kreative-organics-private-limited/a7ac8ac3-c335-4d67-ba2d-5cdc59181996)
- [Cayman Chemical Company, Inc.](https://www.keypedia.com/companies/cayman-chemical-company-inc/8a9655d6-3cec-4e6e-836e-17e9659f3e5b)
- [Yuki Gosei Kogyo Co., Ltd.](https://www.keypedia.com/companies/yuki-gosei-kogyo-co-ltd/94411f09-2744-47ca-9250-20774e61824e)
- [Hubei Yitai Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/hubei-yitai-pharmaceutical-co-ltd/5af81d39-2c88-47d8-b8fc-6627329507f3)
- [Taizhou Xianju Pharmaceutical Co. Ltd.](https://www.keypedia.com/companies/taizhou-xianju-pharmaceutical-co-ltd/4b333061-9eb4-463f-9489-f78b16b0014d)
- [Zhejiang Ausun Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-ausun-pharmaceutical-co-ltd/5c30ecf3-fdd1-4d64-833f-d28cc43b3da4)

## Related Officers

- [Microbiologist](https://www.keypedia.com/people/djamila-harouaka/106cef03-a214-4184-963a-6580d3bd7fd9)
- [Youkeun Kim](https://www.keypedia.com/people/youkeun-kim/94ccfde4-72f7-4df1-9c68-ede73e5e23d0)
- [Investigator](https://www.keypedia.com/people/marcellinus-d-dordunoo/a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a)
